The global urinary incontinence treatment devices market is driven by high prevalence and rapidly increasing incidence of urinary incontinence across the globe. The global market was valued at US$ 2.21 Bn in 2018 and is projected to expand at a CAGR of 7.5% from 2019 to 2027 to reach US$ 4.20 Bn by 2027. High growth of the market is attributed to increase in adoption, easy availability of electrical vaginal stimulation devices, and rise in demand for minimally invasive or non-surgical products across the globe.
Urinary incontinence is defined as involuntary release of urine due to loss of bladder control. Millions of people across the world are affected by urinary incontinence and women are more likely to be affected than men. Urinary incontinence is highly underreported primarily due to embarrassment to speak about it. Over 500 million people across the globe are affected by the condition and its incidence increases with age. Several factors such as urinary tract infection, weakening of pelvic floor muscles & urethral sphincters, menopause, pregnancy & childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence symptoms. According to the International Continence Society, around 12% (both men and women) of the global geriatric population is affected by overactive bladder and its incidence increases with age. In the past few years, various treatment devices such as urethral slings, electrical stimulation devices, artificial urinary sphincters, and catheters have been developed and are increasingly used for effective management of urinary incontinence. Rise in demand for minimally invasive surgery and non-invasive treatment devices and new product launches in the electrical stimulation devices segment are projected to accelerate the growth of the global urinary incontinence treatment devices market during the forecast period.
The global urinary incontinence treatment devices market has been segmented based on product, incontinence type, end-user, and region. In terms of product, the market has been classified into urethral slings, electrical stimulation devices, artificial urinary sphincters, and catheters. The urethral slings segment has been bifurcated into female slings and male slings. The female slings sub-segment dominated the urethral slings segment in 2018. The sub-segment is projected to gain market share from 2019 to 2027. The electrical stimulation devices segment has been categorized into implantable and non-implantable. Medtronic plc’s InterStim device is the only implantable electrical simulation device available in the market for the treatment of overactive bladder symptoms. Vaginal electrical stimulation devices are widely used and demand for these devices is increasing significantly across the globe. Urinary catheters such as Foley catheters, intermittent catheters, and external catheters dominated the global urinary incontinence treatment devices market. High adoption of Foley catheters and intermittent catheters for emptying the bladder, technologically advanced products to prevent infection, and ease of use of intermittent catheters are attributed to the large market share of the catheters segment. Based on incontinence type, the global urinary incontinence treatment devices market has been divided into stress urinary incontinence, urge urinary incontinence, mixed incontinence, and overflow incontinence. The urge incontinence segment dominated the global market in 2018. The segment is anticipated grow at a rapid pace during the forecast period.
In terms of end-user, the global urinary incontinence treatment devices market has been classified into hospitals, ambulatory surgery centers, clinics, and home use. The hospitals segment accounted for major share of the global market in 2018, followed by the ambulatory surgery centers segment. Increase in the number of multinational hospitals with advanced sling surgery techniques such TVT & TOT and adoption of mini slings are expected to boost the growth of the hospitals and ambulatory surgery centers segments during the forecast period.
Geographically, the global urinary incontinence treatment devices market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the global market in 2018, followed by Europe. Well-established health care facilities, favorable reimbursement policies, and early adoption of technologically advanced products for the management of urinary incontinence have contributed to North America’s large market share. Europe is projected to be the most attractive market for urinary incontinence treatment devices from 2019 to 2027. The market in the region is anticipated to expand at the highest CAGR during the forecast period due to high prevalence and increase in incidence of urinary incontinence in the region, recent launch of wearable electrical stimulation devices, and high per capita health care expenditure.
The global urinary incontinence treatment devices market is consolidated, with small number of companies accounting for majority market share. Key players operating in the global market include Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), Coloplast Group, Promedon Group, Medtronic plc, and Ethicon US, LLC. (Johnson & Johnson). These players exhibit significant geographical outreach, with presence in multiple urinary incontinence treatment devices segments. Manufacturers are adopting acquisition & collaboration and new product development strategies to tap the unmet needs of a large proportion of urinary incontinence patient pool. Other prominent players in the global urinary incontinence treatment devices market include ZSI Surgical Implants S.R.L., InControl Medical LLC, Hollister Incorporated, Atlantic Therapeutics Group Ltd., B. Braun Melsungen AG, A.M.I. GmbH, and Teleflex Incorporated.
Increasing Awareness About Health Burden to Spur Urinary Incontinence Treatment Devices Market Growth
A variety of mechanical devices for managing urinary incontinence treatment (UTI) have made commercial launches over the past few years. New designs have come especially targeting women population, and over the years established themselves as a popular alternative to surgery. The substantial health burden UTI carries for both men and women is a key aspect driving the evolution of the urinary incontinence treatment (UTI) devices market. The current demography is a vital factor in driving the development of new devices in the healthcare industry. A growing body of incontinence research has in only in recent years have come to recognize the health-related impact of UTI on sufferers. Thus, policy makers and medical professionals have been supporting funding in the UTI devices market. Particularly, the general public has woken up to the misconception that UTI may just be a normal part of the aging process, or that these effect women in only certain clinical conditions. The changing perception has also encouraged device makers to take interest in the UTI devices market.
Interestingly, developed nations a number of prevalence studies have propelled the prospects of the UTI devices market. Europe, Asia Pacific, and North America have been at the forefront of such studies. The growing demand for devices for controlling adult female urinary incontinence is one of the trends that have kept the UTI devices market lucrative.
The currently emerging Covid-19 has caused wide repercussions on the manufacturing sector across industries. One of the most severely impacted is the medical devices manufacturing. The pandemic-led disruptions in economic activities have been largely responsible for lack of quality clinical data to assess the effectiveness of new devices in the UTI devices market. On the other hand, pharmaceutical industry has in recent months faced some of the severe budget constraints of the decade. This has also shaped the investment priorities of the medical technology companies operating in the UTI devices market. Further, decline in people seeking hospital care has also restrained the potential prospects of the UTI devices market.
The global urinary incontinence treatment devices market has been segmented as follows:
|
Product |
|
|
Incontinence Type |
|
|
End-user |
|
|
Region |
|
Urinary incontinence treatment devices market to reach US$ 4.20 Bn by 2027
Urinary incontinence treatment devices market is projected to expand at a CAGR of 7.5% from 2019 to 2027
Urinary incontinence treatment devices market is driven by high prevalence and rapidly increasing incidence of urinary incontinence across the globe
The urge urinary incontinence segment is projected to dominate the global urinary incontinence treatment market during the forecast period
Key players in the global urinary incontinence treatment devices market include Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), Coloplast Group, Promedon Group, Medtronic plc
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Urinary Incontinence Treatment Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Prevalence of Urinary Incontinence, by Key Region
5.2. Technological Advancements
5.3. Regulatory & Reimbursement Scenario, by Country/Region
5.4. Pricing Analysis, by Electrical Simulation Devices, by Country
5.5. Key Mergers and Acquisitions
5.6. New Product Launch & Approvals
5.7. Guidelines for Managing Urinary Incontinence
5.8. New Approaches and Developments in Urinary Incontinence Treatment Devices
6. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2027
6.3.1. Urethral Slings
6.3.1.1. Female Slings
6.3.1.2. Male Slings
6.3.2. Electrical Stimulation Devices
6.3.2.1. Implantable
6.3.2.2. Non-implantable
6.3.3. Artificial Urinary Sphincters
6.3.4. Catheters
6.4. Market Attractiveness, by Product
7. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Incontinence Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Incontinence Type, 2017–2027
7.3.1. Stress Urinary Incontinence
7.3.2. Urge Urinary Incontinence
7.3.3. Mixed Incontinence
7.3.4. Overflow Incontinence
7.4. Market Attractiveness, by Incontinence Type
8. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Clinics
8.3.4. Home Use
8.4. Market Attractiveness, by End-user
9. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Urinary Incontinence Treatment Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2027
10.2.1. Urethral Slings
10.2.1.1. Female Slings
10.2.1.2. Male Slings
10.2.2. Electrical Stimulation Devices
10.2.2.1. Implantable
10.2.2.2. Non-implantable
10.2.3. Artificial Urinary Sphincters
10.2.4. Catheters
10.3. Market Value Forecast, by Incontinence Type, 2017–2027
10.3.1. Stress Urinary Incontinence
10.3.2. Urge Urinary Incontinence
10.3.3. Mixed Incontinence
10.3.4. Overflow Incontinence
10.4. Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Clinics
10.4.4. Home Use
10.5. Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Incontinence Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Urinary Incontinence Treatment Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2027
11.2.1. Urethral Slings
11.2.1.1. Female Slings
11.2.1.2. Male Slings
11.2.2. Electrical Stimulation Devices
11.2.2.1. Implantable
11.2.2.2. Non-implantable
11.2.3. Artificial Urinary Sphincters
11.2.4. Catheters
11.3. Market Value Forecast, by Incontinence Type, 2017–2027
11.3.1. Stress Urinary Incontinence
11.3.2. Urge Urinary Incontinence
11.3.3. Mixed Incontinence
11.3.4. Overflow Incontinence
11.4. Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Clinics
11.4.4. Home Use
11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Incontinence Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Urinary Incontinence Treatment Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2027
12.2.1. Urethral Slings
12.2.1.1. Female Slings
12.2.1.2. Male Slings
12.2.2. Electrical Stimulation Devices
12.2.2.1. Implantable
12.2.2.2. Non-implantable
12.2.3. Artificial Urinary Sphincters
12.2.4. Catheters
12.3. Market Value Forecast, by Incontinence Type, 2017–2027
12.3.1. Stress Urinary Incontinence
12.3.2. Urge Urinary Incontinence
12.3.3. Mixed Incontinence
12.3.4. Overflow Incontinence
12.4. Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Clinics
12.4.4. Home Use
12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Incontinence Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Urinary Incontinence Treatment Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2027
13.2.1. Urethral Slings
13.2.1.1. Female Slings
13.2.1.2. Male Slings
13.2.2. Electrical Stimulation Devices
13.2.2.1. Implantable
13.2.2.2. Non-implantable
13.2.3. Artificial Urinary Sphincters
13.2.4. Catheters
13.3. Market Value Forecast, by Incontinence Type, 2017–2027
13.3.1. Stress Urinary Incontinence
13.3.2. Urge Urinary Incontinence
13.3.3. Mixed Incontinence
13.3.4. Overflow Incontinence
13.4. Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Clinics
13.4.4. Home Use
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Incontinence Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Urinary Incontinence Treatment Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2027
14.2.1. Urethral Slings
14.2.1.1. Female Slings
14.2.1.2. Male Slings
14.2.2. Electrical Stimulation Devices
14.2.2.1. Implantable
14.2.2.2. Non-implantable
14.2.3. Artificial Urinary Sphincters
14.2.4. Catheters
14.3. Market Value Forecast, by Incontinence Type, 2017–2027
14.3.1. Stress Urinary Incontinence
14.3.2. Urge Urinary Incontinence
14.3.3. Mixed Incontinence
14.3.4. Overflow Incontinence
14.4. Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Ambulatory Surgery Centers
14.4.3. Clinics
14.4.4. Home Use
14.5. Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Incontinence Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Company Profiles
15.2.1. Boston Scientific Corporation
15.2.2. C. R. Bard, Inc. (Becton, Dickinson and Company)
15.2.3. Coloplast Group
15.2.4. Promedon Group
15.2.5. A.M.I. GmbH
15.2.6. Ethicon US, LLC. (Johnson & Johnson)
15.2.7. ZSI Surgical Implants S.R.L.
15.2.8. Medtronic plc
15.2.9. InControl Medical LLC
15.2.10. Hollister Incorporated
15.2.11. Atlantic Therapeutics Group Ltd.
15.2.12. B. Braun Melsungen AG
15.2.13. Teleflex Incorporate
Table 01: Global Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Urethral Slings, 2017–2027
Table 03: Global Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Electrical Stimulation Devices, 2017–2027
Table 04: Global Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Incontinence Type, 2017–2027
Table 05: Global Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 09: North America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Urethral Slings, 2017–2027
Table 10: North America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Electrical Stimulation Devices, 2017–2027
Table 11: North America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Incontinence Type, 2017–2027
Table 12: North America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 13: Europe Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14: Europe Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
Table 15: Europe Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast, by Urethral Slings, 2017–2027
Table 16: Europe Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast, by Electrical Stimulation Devices, 2017–2027
Table 17: Europe Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast, by Incontinence Type, 2017–2027
Table 18: Europe Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027
Table 19: Asia Pacific Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Asia Pacific Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 21: Asia Pacific Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Urethral Slings, 2017–2027
Table 22: Asia Pacific Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Electrical Stimulation Devices, 2017–2027
Table 23: Asia Pacific Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Incontinence Type, 2017–2027
Table 24: Asia Pacific Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 25: Latin America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Latin America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 27: Latin America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Urethral Slings, 2017–2027
Table 28: Latin America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Electrical Stimulation Devices, 2017–2027
Table 29: Latin America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Incontinence Type, 2017–2027
Table 30: Latin America Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 31: Middle East & Africa Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 32: Middle East & Africa Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 33: Middle East & Africa Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Urethral Slings, 2017–2027
Table 34: Middle East & Africa Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Electrical Stimulation Devices, 2017–2027
Table 35: Middle East & Africa Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by Incontinence Type, 2017–2027
Table 36: Middle East & Africa Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Figure 01: Global Urinary Incontinence Treatment Devices Market Size (US$ Mn) Forecast, 2017–2027
Figure 02: Market Value Share, by Product, 2018
Figure 03: Market Value Share, by Incontinence Type, 2018
Figure 04: Market Value Share, by End-user, 2018
Figure 05: Market Value Share, by Region, 2018
Figure 06: Global Urinary Incontinence Treatment Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 07: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 08: Global Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Urethral Slings, 2017–2027
Figure 09: Global Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Electrical Stimulation Devices, 2017–2027
Figure 10: Global Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Artificial Urinary Sphincters, 2017–2027
Figure 11: Global Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Catheters, 2017–2027
Figure 12: Global Urinary Incontinence Treatment Devices Market Value Share Analysis, by Incontinence Type, 2018 and 2027
Figure 13: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2019–2027
Figure 14: Global Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Stress Urinary Incontinence, 2017–2027
Figure 15: Global Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Urge Urinary Incontinence, 2017–2027
Figure 16: Global Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Mixed Incontinence, 2017–2027
Figure 17: Global Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Overflow Incontinence, 2017–2027
Figure 18: Global Urinary Incontinence Treatment Devices Market Value Share Analysis, by End-user, 2018 and 2027
Figure 19: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2019–2027
Figure 20: Global Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 21: Global Urinary Incontinence Treatment Devices Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Ambulatory Surgery Centers, 2017–2027
Figure 22: Global Urinary Incontinence Treatment Devices Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Clinics, 2017–2027
Figure 23: Global Urinary Incontinence Treatment Devices Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Home Use, 2017–2027
Figure 24: Global Urinary Incontinence Treatment Devices Market Value Share, by Region, 2018 and 2027
Figure 25: Global Urinary Incontinence Treatment Devices Market Attractiveness, by Region, 2019–2027
Figure 26: North America Urinary Incontinence Treatment Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 27: North America Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country, 2018 and 2027
Figure 28: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country, 2018-2026
Figure 29: North America Urinary Incontinence Treatment Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 30: North America Urinary Incontinence Treatment Devices Market Value Share Analysis, by Incontinence Type, 2018 and 2027
Figure 31: North America Urinary Incontinence Treatment Devices Market Value Share Analysis, by End-user, 2018 and 2027
Figure 32: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 33: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2019–2027
Figure 34: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2019–2027
Figure 35: Europe Urinary Incontinence Treatment Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 36: Europe Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 37: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 38: Europe Urinary Incontinence Treatment Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 39: Europe Urinary Incontinence Treatment Devices Market Value Share Analysis, by Incontinence Type, 2018 and 2027
Figure 40: Europe Urinary Incontinence Treatment Devices Market Value Share Analysis, by End-user, 2018 and 2027
Figure 41: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 42: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2019–2027
Figure 43: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2019–2027
Figure 44: Asia Pacific Urinary Incontinence Treatment Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 45: Asia Pacific Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 46: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
Figure 47: Asia Pacific Urinary Incontinence Treatment Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 48: Asia Pacific Urinary Incontinence Treatment Devices Market Value Share Analysis, by Incontinence Type, 2018 and 2027
Figure 49: Asia Pacific Urinary Incontinence Treatment Devices Market Value Share Analysis, by End-user, 2018 and 2027
Figure 50: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 51: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2019–2027
Figure 52: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2019–2027
Figure 53: Latin America Urinary Incontinence Treatment Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 54: Latin America Urinary Incontinence Treatment Devices Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 55: Latin America Urinary Incontinence Treatment Devices Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 56: Latin America Urinary Incontinence Treatment Devices Market Value Share, by Product, 2018 and 2027
Figure 57: Latin America Urinary Incontinence Treatment Devices Market Value Share, by Incontinence Type, 2018 and 2027
Figure 58: Latin America Urinary Incontinence Treatment Devices Market Value Share, by End-user, 2018 and 2027
Figure 59: Latin America Urinary Incontinence Treatment Devices Market Attractiveness, by Product, 2019–2027
Figure 60: Latin America Urinary Incontinence Treatment Devices Market Attractiveness, by Incontinence Type, 2019–2027
Figure 61: Latin America Urinary Incontinence Treatment Devices Market Attractiveness, by End-user, 2019–2027
Figure 62: Middle East & Africa Urinary Incontinence Treatment Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 63: Middle East & Africa Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 64: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 65: Middle East & Africa Urinary Incontinence Treatment Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 66: Middle East & Africa Urinary Incontinence Treatment Devices Market Value Share Analysis, by Incontinence Type, 2018 and 2027
Figure 67: Middle East & Africa Urinary Incontinence Treatment Devices Market Value Share Analysis, by End-user, 2018 and 2027
Figure 68: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 69: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2019–2027
Figure 70: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2019–2027
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Urinary Incontinence Treatment Devices Market, Forecast 2019 - 2027
